with GWAS has been its inability to translate potential causal SNPs to understanding mechanistically how these variants confer risk. The approach taken by MacLeod et al. (2013) offers us a lesson on how functional studies in model systems can be combined with unbiased human genetics and genomics studies to help elucidate novel genetic contributors to PD and many other human diseases.
In parallel to the tremendous genetic advances, there has been a recent seismic shift in understanding of mechanisms of PD initiation and progression. Neuropathologists have long appreciated that PD is characterized by widespread changes, involving both the peripheral and central nervous system (Braak et al., 2003) . Remarkably, alpha-synuclein, the pathological substrate of Lewy bodies, seems to be able to spread from neuron to neuron and to propagate throughout anatomically interconnected brain regions. Indeed, a single injection of a preparation of alpha-synuclein aggregates into the mouse striatum is sufficient to kick off an inexorable spread of PD-like pathology and progressive loss of dopaminergic neurons, decreased dopamine levels, and eventual motor impairments (Luk et al., 2012) . It is now clear that alpha-synuclein spread is a critical aspect in PD pathogenesis (Goedert et al., 2012) .
A challenge will now be to integrate the genetic and pathological breakthroughs in order to define how the genetic susceptibility factors interface with alpha-synuclein spread. Do genetic loci linked to PD increase risk of disease, at least in part, by enhancing the initiation or accelerating the spread of alpha-synuclein pathology? Although this study focused on LRRK2 and PARK16, similar approaches can be launched to analyze potential interactions between other genetic susceptibility factors, including alpha-synuclein. One day, these parallel approaches may converge on a common pathway. Whether neurons generated in vitro from human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) have in vivo-like properties is unknown. In this issue of Neuron, Espuny-Camacho et al. (2013) show that ESC-/iPSC-derived cortical neurons make specific projections and functional synapses when transplanted into a neonatal mouse brain.
In Vitro Human Corticogenesis
Efforts to study the development of the human cerebral cortex have been complicated by the difficulty of obtaining human fetal brain tissue. An attractive solution to this problem is to use human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) to recapitulate human brain development in vitro or in experimental animals. Over the last decade, several methods have been developed for making cortical neurons from human ESCs and iPSCs. However, it is not clear how well neuron development in vitro recapitulates neuron development in vivo or whether neurons generated in vitro have the same properties as neurons in vivo.
The development of the human brain is guided by a combination of intrinsic signals, morphogens, and electrical events. Guided by experiments first conducted in Xenopus and subsequently in mouse ESCs, a number of groups have developed methods for directing ESCs and iPSCs to generate cortical neurons (Eiraku et al., 2008; Li et al., 2009; Pas xca et al., 2011) . The basic approach starts with a step of neural induction in which ESCs are differentiated into neuroectoderm by removal of fibroblast growth factor. Generation of neurons with rostral and dorsal cell fates largely occurs by a default pathway leading to the sequential generation of a diverse repertoire of cortical projection neurons. Two different approaches are widely used for generating cortical neuronal precursors and neurons. The first, pioneered by Sasai and colleagues (Eiraku et al., 2008) , relies on the generation of cell clusters called embryoid bodies that form selforganized clusters of neural progenitor cells that generate cortical neurons. The neurons generated using this method recapitulate the time course of corticogenesis and express markers for lower and upper layer neurons as well as for callosal and subcortical projection neurons.
A second approach developed by Studer and his colleagues starts with cell monolayers and relies on Noggin and SB431542 to synergistically inhibit SMAD signaling, resulting in a rapid and complete neural conversion (Chambers et al., 2009 ). This method offers more uniform cell populations but loses the three-dimensional cellular arrangement of the embryoid body method (Chambers et al., 2009 ). This approach has been used to generate polarized rosettes that constitute three distinct populations of cortical stem and progenitor cells. These cells recapitulate the cell types that are present in the germinal zone of the developing human cortex (Hansen et al., 2010) and produce a diversity of upper and lower layer cortical projection neurons that have mature electrical properties and form functional synapses (Shi et al., 2012) .
Although substantial progress has been made in developing protocols to generate cortical neurons in vitro, the anatomical and functional properties of these cells has not been studied. In this issue of Neuron, Espuny-Camacho et al. (2013) successfully tackle this question by using a combination of the two methods to differentiate ESCs and iPSCs into cortical neurons. They characterize these cells in vitro and transplant them after 24 days in vitro into the neonatal mouse frontal cortex to study their properties in vivo. They analyze cell fate, dendrite arborization, and axon projection patterns, as well as the electrophysiological features of the cells.
As has been shown previously, Espuny-Camacho et al. (2013) observed that inner layer neurons were generated early, whereas outer layer neurons were generated later in the differentiation process. This recapitulates the temporal pattern of neuronal production in vivo. They observed a higher proportion of upper layer neurons after transplantation than were observed in vitro after differentiation, suggesting that in vivo cues are important for the full generation of late-born upper layer neurons. When they examined synapse formation, Espuny- Camacho et al. (2013) discovered that 9 months after transplantation, most neurons had elaborate dendrites and numerous dendritic spines. Using electron microscopy and immunolabeling with anti-GFP antibodies, they identified numerous synapses from the grafted neurons to the host cells and vice versa, revealing that grafted human neurons can form synapses with mouse cells. To show that these synapses were functional, Espuny-Camacho et al. In the mouse cortex, areal patterning is established by the graded expression of key transcription factors in the dorsal telencephalon that are regulated by gradients of morphogens such as FGFs, Wnts, and BMPs. Several groups have applied these developmental principles to differentiate mouse ESCs into cortical projection neurons with specific identities. However, attempts to selectively control the regional identity of human ESC-derived cortical neurons have lagged behind. Espuny-Camacho et al. (2013) observed that human cortical cell transplantation into the frontal cortex initially extended axonal projections that were not characteristic of frontal lobe pyramidal neurons. Instead, these cells extended axons to targets that are innervated by occipital (visual) and limbic cortical neurons and expressed the marker COUP-TFI, suggesting that they have a limbic and occipital cell fate. After longer periods of time, however, the neurons were found to project to a wider range of targets, including motor and somatosensory cortex, suggesting that a proportion of the grafted cells can be respecified by environmental cues. This plasticity has been reported by Ideguchi et al., who discovered that mouse ESC-derived early progenitors adopted the areal identity of their transplantation site, sending long-distance axons to the appropriate subcortical targets (Ideguchi et al., 2010) .
In addition to studying the anatomical properties of ESC-and iPSC-derived neurons, Espuny-Camacho et al. (2013) also compared transcriptomes of differentiating ESC-derived cortical neurons in vitro and samples of human embryonic dorsal telencephalon at 9 and 19 gestational weeks. They concluded that the transcriptional profiles of ESCderived cortical neurons closely correlated with their fetal cortical counterparts between these two stages of human brain development. This is important because it provides additional evidence that in vitro maturation closely mimics in vivo maturation at a transcriptional level and suggests that stem cell models accurately recapitulate human cortical development.
The mechanisms that control neuronal specification in humans are not known, and this study raises a number of interesting questions. Based on the current results, it appears that occipital cortex is the default fate but that some precursors have limited plasticity if transplanted into other areas of cortex. The types of precursor cells that have this plasticity and the mechanisms that underlie it are ripe for investigation. A second interesting issue concerns the dramatic temporal contrast between mouse and human neural development. In vitro mouse neural precursors mature within days or weeks, whereas maturation of human neural precursors takes months even when cells are transplanted into mice. This suggests that the rate of neuronal maturation is an intrinsic property of each species and raises questions about the underlying mechanisms that result in this difference between species.
In summary, this study provides the most comprehensive characterization to date of the properties of human neurons developed from ESCs and iPSCs in culture. It shows that these cells are able to recapitulate in vivo development and form connections and projections to a remarkable degree. These findings set the stage for a more comprehensive use of human stem cells to study normal human brain development under both physiological and pathological conditions. In combination with recent developments in genome engineering and the generation of libraries of iPSCs from patients with neurodevelopmental disease, ESC-and iPSC-based models will be a powerful tool for basic and translational studies.
